3 stories mentioning SASE:4164Updated just now
Every FINWIRES story that references SASE:4164, newest first.
Morgan Stanley on Wednesday lowered the price target for retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 112 Saudi riyals from 120 riyals, while maintaining its overweight rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Morgan Stanley on Thursday reduced the price target for Saudi Arabian retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 120 Saudi riyals from 135 riyals and affirmed its overweight rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Riyad Capital on Thursday downgraded pharmaceutical retailer Nahdi Medical (SASE:4164) to neutral from buy and decreased its price target to 105 Saudi riyals from 115 riyals.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
